Management Forum Logo

Presented by
Management Forum

FDA (Food and Drug Administration) Approval Process for Medical Devices Training Course

This seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States including the underlying legal and regulatory requirements and the 'general controls' applicable to all devices.

19-20 June 2024
+ 10-11 September 2024, 2-3 December 2024 »

from £1099

Need help?  Enrol or reserve

Course overview

This seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States. Participants will gain an understanding of the underlying legal and regulatory requirements and the general controls applicable to all devices, including device classification, establishment registration and device listing. With the underlying framework in mind, the approval and clearance processes for new and modified devices will be presented, including 510(k), IDE, PMA, HDE and De Novo applications. Application contents, review processes, timelines, and key guidance documents will be discussed for each major type of submission. Participants will also learn about the pre-submission process, which FDA strongly recommends to help ensure the successful submission of novel devices.

Case studies will help participants to put some of the learnings into practice and to use FDA databases to research example products. The course includes up to date information which covers recent changes in legislation, regulations and guidance. Please note that the trainer has recent experience with both medical devices and in vitro diagnostics. However, please not that the course covers medical devices in general and does not provide separate sessions for specific types of medical devices (such as IVDs, software, etc). 

This course is of our range of Medical Devices training courses - now also including Medical Devices Cyber Security training to help improve your data security.

Benefits of attending

Upon completion of this seminar, participants will:

  • Understand the overall FDA medical device regulatory process
  • Know what is required for 510(k), IDE, PMA, HDE and De Novo applications
  • Understand how FDA processes premarket submissions
  • Identify key guidance documents to help ensure a successful process
  • Determine when pre-submission interaction with FDA is recommended
  • Be aware of areas of change

Who should attend

This seminar is intended for regulatory, technical, clinical and quality professionals who require an understanding of the FDA medical device approval process. Management, legal, medical, marketing and other professionals who are interested in understanding the key principles of the medical device approval process will also benefit in attending.

New

Enrol or reserve

The FDA Approval Process for Medical Devices course will cover:

MODULE 1 – Overview of US Medical Device Regulatory Principles


Part 1 - Introduction to US FDA

History, Structure and Mission of FDA


Part 2 - Overview of US Regulatory Process and Pathway

Including how to work with FDA and pre-submissions (Q-subs)

MODULE 2 – Medical Device Definition, Classification, Device Listing & Establishment Registration


Part 1 - Medical Device Definition, Classification, Device Listing & Establishment Registration


Part 2 – Classification Case Study


MODULE 3 – Submissions


Part 1 - Pre-Market Notification 510(k)


Part 2 – De-Novo / Automatic Class III Reclassification


Part 3 - Pre-Market Approval (PMA)


Part 4 – HDE & IDE (& IUO)


Part 5 – Submission Case Study


MODULE 4 – Borderline & Combination Products

Product Designation & Combination Products

Enrol or reserve

Jonathan Hughes
JHRA Ltd

Jonathan Hughes, Ph.D., FTOPRA, has over 35 years of worldwide regulatory and clinical affairs experience across medical devices, drug / biologic – device combination products and in-vitro diagnostics. He has worked with medical device and pharmaceutical companies, both large and small, across multiple locations to help develop and execute regulatory strategies for market clearance, approval and access.

Jonathan has hands-on experience in a variety of therapeutic areas and has worked across different technologies and types of medical products including medicated devices (devices containing ancillary drug and biologic constituents), drug delivery systems and componentry, sterile and non-sterile disposables and durable equipment, in-vitro diagnostics, software controlled devices and standalone software (including mobile apps). He has experience of regulating medical devices and combination products across most international markets including the European Union, US, Japan, China, Canada and Australia.

Jonathan specialises in regulatory strategy, regulatory and clinical development pathways, worldwide regulatory submissions and training. He has a strong knowledge of quality management systems and has direct hands-on experience of US FDA, MDSAP, EU NB, Brazilian ANVISA and Chinese NMPA inspections. He has worked with all the major international regulatory agencies, in particular (multiple) Notified Bodies and US FDA, EU Competent Authorities, Japanese PMDA, Chinese NMPA.

Jonathan has served on two European Commission Expert Working Groups on the Drug / Device Borderline and Device Classification. He is a Fellow of the regulatory professional organisation, TOPRA, and is a regular contributor on numerous educational and training programmes. Jonathan has registered teacher status at Cranfield University, is a Visiting Industrial Fellow at the University of Hertfordshire and also a visiting lecturer at University of Newcastle upon Tyne.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

19-20 June 2024

Live online

09:15-17:00 UK (London) (UTC+01)
10:15-18:00 Paris (UTC+02)
04:15-12:00 New York (UTC-04)
Course code 13735

  • GBP 1,099 1,299
  • EUR 1,589 1,869
  • USD 1,817 2,129

Until 15 May

View basket 

 
Not ready to book yet?

for 7 days, no obligation

10-11 September 2024

Classroom
Rembrandt Hotel
London

09:00-17:00 UK (London)
Course code 13897
Optional £240/€312/$360 per night

  • GBP 1,299 1,499
  • EUR 1,869 2,149
  • USD 2,137 2,449

Until 06 Aug

  • 2 days classroom-based training
  • Optional accommodation - 2 nights including breakfast, checking in the day before the course
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

View basket 

 
Not ready to book yet?

for 7 days, no obligation

2-3 December 2024

Live online

09:15-17:00 UK (London) (UTC+00)
10:15-18:00 Paris (UTC+01)
04:15-12:00 New York (UTC-05)
Course code 14068

  • GBP 1,099 1,299
  • EUR 1,589 1,869
  • USD 1,817 2,129

Until 28 Oct

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

United Kingdom

  • 3M Healthcare Ltd
  • 42 Technology Ltd
  • AbbVie
  • Acrobot Company Ltd
  • Alere Technologies AS
  • Allergan Limited
  • Alliance Healthcare
  • Annette Callaghan Ltd
  • Arakis Ltd
  • Bedfont Scientific Ltd
  • Bespak Europe Ltd
  • Bibra Toxicology Advice & Consulting
  • Biogen Idec Ltd
  • Bioquell UK Ltd
  • Britannia Pharmaceuticals Ltd
  • CAMBRIDGE BIOSTABILITY
  • Cambridge Design Partnership
  • Carl Zeiss Meditec
  • ConvaTec Ltd
  • ConvaTec UK Ltd
  • Corin Group Plc
  • Corin Limited
  • Covidien (UK) Commerical Limited
  • COZART
  • CPI
  • DCA Design International
  • De Soutter Medical
  • Depuy CMW
  • DePuy International Limited
  • Ethicon, Division of Johnson & Johnson Medical
  • FMP Ltd
  • GAMA Healthcare Ltd
  • GBUK Limited
  • Glysure Limited
  • GSK Consumer Healthcare
  • Haleon
  • Huntleigh Technology Limited
  • Hyaltech Ltd.
  • IDC ltd
  • Imperial College London
  • Industrial Design Consultancy Limited
  • Informa Healthcare Limited
  • Intelligent Ultrasound
  • Isotron Ltd
  • JOHNSON & JOHNSON
  • Johnson & Johnson Medical Ltd
  • JRI Orthopaedics Limited
  • KCI UK Holdings Ltd
  • Lifescan Scotland Ltd
  • MAGSTIM CO LTD
  • Magstim Company Ltd
  • Mayborn Group
  • MedAlliance
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Mediqol Limited
  • Medtrade Products Ltd
  • Microvisk Technologies
  • NGPOD
  • Nobel Biocare
  • Norgine Limited
  • Olympus KeyMed Ltd
  • Optos plc
  • Ortho-Clinical Diagnostics (Johnson & Johnson)
  • OrthoMimetics Ltd
  • OrthoSon
  • Orthoson Ltd.
  • Owen Mumford
  • Owen Mumford Ltd
  • Owlstone
  • Owlstone Medical
  • PA Consluting
  • PA Consulting
  • PA Consulting Group
  • Pan Medical Ltd
  • PEARSALLS LTD
  • Pfizer
  • Pfizer R&D UK Ltd
  • Probus Regulatory Services Ltd
  • Quanta Dialysis Technologies Ltd
  • Reckitt Benckiser
  • Reckitt Benckiser Healthcare (UK) Ltd
  • Renishaw plc
  • RSB Projects Ltd
  • Russell Square Quality Associates Limited
  • Sagentia Limited
  • Sanguin International
  • Sauflon Pharmaceuticals Ltd
  • SGR Consulting Services Ltd
  • Sharp Life Science (EU) Ltd
  • Sinclair Pharma
  • Sinclair Pharma Plc
  • Sinclair Pharmaceuticals
  • Smith & Nephew Wound Management
  • Smiths Medical International Ltd
  • Speciality Fibres and Materials Limited
  • Sphere Medical Ltd
  • Stanmore Implants Worldwide Limited
  • Technology Partnership Plc
  • Teva Pharmaceuticals Runcorn
  • Tissue Science Laboratories PLC
  • Ultromics Ltd
  • UNIVERSITY OF BRISTOL
  • University of Manchester Intellectual Property Ltd
  • Unomedical Ltd
  • VASCUTEK LTD
  • Vectura Group plc
  • Wesley Coe Limited
  • Xiros
  • XIROS PLC
  • Zilico

Germany

  • Abbott GmbH & Co. KG
  • Abbott Products GmbH
  • Acandis GmbH
  • Boehringer Ingelheim Pharma GmbH & Co KG
  • Carl Zeiss AG
  • Dr Suwelack Nachf Gmbh & Co KG
  • Essity - BSN medical GmbH
  • HEXAL
  • ING. ERICH PFEIFFER GmbH
  • MEDTRON AG
  • Miltenyi Biotec GmbH
  • Olympus Surgical Technologies Europe
  • Pfenning Meinig & Partner
  • Roche Diabetes Care GmbH
  • Roche Diagnostics GmbH
  • Sanofi-Aventis Deutschland GmbH
  • Siemens AG
  • Siemens Healthcare GmbH
  • Stryker Leibinger GmbH & Co Kg

Ireland

  • ABBOTT IRELAND
  • Aerogen Ltd
  • Boston Scientific
  • Boston Scientific Ireland Ltd
  • Cook Ireland Ltd
  • ELAN PHARMA TECHNOLOGIE
  • Henkel Ireland Limited
  • INAMED AESTHETICS
  • Medtronic Ireland
  • Merit Medical
  • Merit Medical Ireland Ltd
  • RESPIRONICS (IRELAND) LTD
  • SWORDS LABORATORIES LTD
  • Tech Group Europe

Switzerland

  • Bayer Consumer Health Devision
  • Biotronik AG
  • BÜHLMANN Laboratories AG
  • Celgene International Sarl
  • DSM Nutritional Products Ltd Branch Pentapharm
  • Imtool Sarl
  • Institut Straumann AG
  • ISS AG, Integrated Scientific Services
  • Medtronic International Trading Sarl
  • Nobel Biocare
  • Nobel Biocare AB
  • Novartis Vaccines & Diagnostics AG
  • Rising Tide
  • ZIMMER GMBH

France

  • Air Liquide Santé International
  • Becton Dickinson
  • Biosphere Medical SA
  • Boston Scientific Corp
  • Cabinet Michel Richebourg
  • CyberConseil
  • Galderma R&D
  • Guerbet
  • IHU Strasbourg
  • Sanofi-Aventis Groupe
  • Sanofi-Aventis R&D
  • Tornier SAS

Denmark

  • Engineers & Doctor As
  • Ferring Pharmaceuticals A/S
  • FERROSAN A/S
  • LAB Research (Scantox)
  • Leo Pharma A/S
  • Neurodan A/S
  • Novo Nordisk A/S
  • RSP Systems
  • RSP Systems A/S
  • Unomedical A/S
  • William Cook Europe ApS

Sweden

  • AstraZeneca AB
  • Baxter
  • BONESUPPORT AB
  • DENTSPLY Implants
  • Euro Diagnostica AB
  • Glycorex Transplantation AB
  • HemoCue AB
  • Mölnlycke Health Care AB
  • Q-Med AB
  • Wellspect Healthcare
  • XVIVO Perfusion AB

Italy

  • Diasorin S.p.A
  • Digitec S.r.l.
  • Epygon Italie srl
  • Eurofins Biolab Srl
  • Eurofins Medical Device Testing
  • Invatec SRL
  • Orthofix Srl
  • Sigea Srl
  • Sorin Group Italia srl

Netherlands

  • Aqtis Medical
  • Biotop Medical
  • Merck Sharp & Dohme
  • MRC-Holland BV
  • Philips Consumer Lifestyle
  • POLYGANICS BV

Belgium

  • Fujirebio-Europe NV
  • IBA
  • Janssen Pharmaceutica NV
  • Oystershell NV
  • Rousselot BV

Spain

  • Diagnostic Grifols S.A.
  • Diagnostic Grifols SA
  • Diagnostic Grifols, S.A.
  • Grifols S.A
  • Grifols S.A.

United States of America

  • ARROW INTERNATIONAL INC
  • Edwards Lifesciences Corp
  • NAMSA
  • North American Science Associates
  • Thermo Fisher Scientific

Austria

  • Baxter Innovations GmbH
  • MED-EL Medical Electronics
  • PRO-MED AG

Finland

  • Medix Biochemica
  • Orion Pharma
  • WALLAC OY

Saudi Arabia

  • Gulf Health Council
  • SAUDI FOOD & DRUG AUTHORITY
  • Saudi Food and Drug Authority

Czech Republic

  • Contipro Pharma as
  • Teleflex Medical

Korea, Republic Of

  • Dongguk University
  • 동국대학교

Norway

  • EpiGuard
  • Lyfstone

Poland

  • LiNA Medical Polska Sp. z o.o.
  • LiNA Medical Sp. z o.o.

Portugal

  • Instituto Pedro Nunes - PT502790610
  • IPN

Canada

  • Medicenna Therapeutics Inc

India

  • QUINTILES RESEARCH (INDIA) PRIVATE

Japan

  • Jimro Co Ltd

Malta

  • Baxter Healthcare Corp

Russia

  • CWT Russ LLC

Turkey

  • NEMED Tibbi Urunler

Enrol or reserve

Run FDA Approval Process for Medical Devices Live online/Classroom for your team

2 days

Typical duration

Pricing from:

  • GBP 800
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Yesim NURKO
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy